Johnson & Johnson Hikes Earnings Guidance but Pharma Growth Masks a MedTech Stumble. Stock Falls. Johnson & Johnson Hikes Earnings Guidance but Pharma Growth Masks a MedTech Stumble. Stock Falls. · Barrons.com · Mark Ralston/AFP via Getty Images Mackenzie Tatananni Tue, October 13, 2026 at 7:29 AM EDT 2 min read JNJ +0.88% APO +0.48% MRK -0.10% ^GSPC -0.06% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Johnson & Johnson says it is working to improve results in its medical-device business, where surgery revenue fell for the latest quarter.
